Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation.
Franz ZehentmayrMartin SprengerLukas RettenbacherRomana WassPeter PorschGerd FastnerChristian PirichMichael StudnickaFelix SedlmayerPublished in: Thoracic cancer (2019)
OS and CSS in early lung cancer patients depend on comorbidity rather than on pathological confirmation of disease.